this series of FREE webinars, we team up with Macmillan Cancer Support and get to quiz several consultant oncologists to demystify some of the conundrums posed by cancer in primary care.
Live date: 11.03.2020
CPD points: 1Info / BookAdd to basket
Join Dr David Plume and guests as they discuss the many issues, guidelines, studies and effects around prostate cancer.
Prostate cancer is the most common cancer in the UK with around 48,000 men a year diagnosed. It can cause premature death, but actually has quite low mortality rates even with advanced disease, unlike many of the cancers that we see.
It’s no surprise therefore that we see a lot of men who are either concerned about prostate cancer, are being treated or monitored with prostate cancer, or have had prostate cancer in the past and are now dealing with the consequences of treatment, and as we move to stratified follow up, and more low risk prostate cancer patients are followed up in the community rather than secondary care, we will see many more!
Join Cancer Course Director Dr David Plume in the Red Whale studio with co-host Dr Richard Simcock, Consultant Clinical Oncologist from Brighton and one of Macmillan’s Consultant Advisors, and our guest Dr Alison Birtle, Consultant Clinical Oncologist and Honorary Clinical Senior Lecturer from Lancashire Teaching Hospitals NHS Foundation Trust.
What we will cover:
- Significant issues around the diagnosis and management of prostate cancer.
- The NICE Guidelines on prostate cancer.
- The STAMPEDE study and what this might mean for our patients.
- Late and long term effects from prostate cancer treatment.